Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 19 citing articles:

Emerging Applications of Nanoparticles in the Diagnosis and Treatment of Breast Cancer
Josephine B. Oehler, Weranga Rajapaksha, Hugo Albrecht
Journal of Personalized Medicine (2024) Vol. 14, Iss. 7, pp. 723-723
Open Access | Times Cited: 16
Metabolic dysfunction-associated steatotic liver disease: A sexually dimorphic disease and breast and gynecological cancer
Xinrong Zhang, Mindie H. Nguyen
Metabolism (2025), pp. 156190-156190
Closed Access | Times Cited: 1
Hypomethylating agents as emerging therapeutics for triple-negative breast cancer
Nik Mohd Asri Nik Amirah Auni, Norhanani Mohd Redzwan, Agustine Nengsih Fauzi, et al.
Life Sciences (2025), pp. 123403-123403
Closed Access
A novel formula to improve the accuracy and prognostic ability of determining the survival time after recurrent breast cancer
Reiki Nishimura, Yasuaki Sagara, Reiko Mitsueda, et al.
Breast Cancer (2025)
Closed Access
Development of a prognostic model based on the ceRNA network in Triple-Negative Breast cancer
Yimin Zhu, Jiayu Wang, Binghe Xu
PeerJ (2025) Vol. 13, pp. e19063-e19063
Open Access
Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells
Tânia Moura, Paula Laranjeira, Olga Caramelo, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 143-143
Open Access
Therapeutic implications of Epirubicin-induced miRNA-22 and miRNA-331 upregulation on cell viability and metastatic potential in triple-negative breast cancer
Somayeh Farahmand, Saber SamadiAfshar, Mahsa Khalili, et al.
Human Gene (2025), pp. 201396-201396
Closed Access
Carcinoma Metaplásico de Mama: Diagnóstico e Abordagem Multidisciplinar em Caso de Subtipo Raro
Rita D. Brandão, Mateus Oliveira, Rafael Isaque Lira do Nascimento, et al.
Revista Brasileira de Cancerologia (2025) Vol. 71, Iss. 2, pp. e-024981
Open Access
PFDN1 silencing disrupts critical cancer pathways in triple-negative breast cancer: investigating migration, cell cycle, and apoptosis as a new target therapy
Abdulrahman M. Alokda, Ahmed Soffar, Amany I. Yousef, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Neoadjuvant Strategies for Triple Negative Breast Cancer: Current Evidence and Future Perspectives
Zhenjun Huang, Qing Peng, Luhui Mao, et al.
MedComm – Future Medicine (2025) Vol. 4, Iss. 1
Open Access
BUB1 Inhibition Induces Ferroptosis in Triple-Negative Breast Cancer Cell Lines
Sushmitha Sriramulu, Shivani Thoidingjam, Stephen L. Brown, et al.
DNA (2025) Vol. 5, Iss. 1, pp. 16-16
Open Access
Evaluation of CircHIPK3 Biomarker Potential in Breast Cancer
Ensiyeh Bahadoran, Davood Mohammadi, Manijeh Jalilvand, et al.
Practical Laboratory Medicine (2025), pp. e00470-e00470
Open Access
Mapping molecular landscapes in triple-negative breast cancer: insights from spatial transcriptomics
Fares Saeed H. Al-Mansour, Hassan H. Almasoudi, Ali Albarrati
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Anti-cancer effects of Plumbago zeylanica L. against human triple-negative breast cancer: Insights from network pharmacology and in-vitro experimental validation
Arif Jamal Siddiqui, Ahmed Mohajja Alshammari, Mitesh Patel, et al.
South African Journal of Botany (2025) Vol. 180, pp. 795-810
Closed Access
Impact of Neoadjuvant Therapy on PD-L1 Expression in Triple-Negative Breast Cancer and Correlation with Clinicopathological Factors
Nevena Ilieva, Mina Pencheva, Hristo Hadzhiev, et al.
Diagnostics (2024) Vol. 14, Iss. 23, pp. 2672-2672
Open Access | Times Cited: 1
Targeting DNA damage repair mechanism by using RAD50-silencing siRNA nanoparticles to enhance radiotherapy in triple negative breast cancer
Abdulmottaleb E. Zetrini, Azhar Z. Abbasi, Chunsheng He, et al.
Materials Today Bio (2024) Vol. 28, pp. 101206-101206
Open Access | Times Cited: 1
Combinatory Effect of Pequi Oil (Caryocar brasiliense)-Based Nanoemulsions Associated to Docetaxel and Anacardic Acid (Anacardium occidentale) in Triple-Negative Breast Cancer Cells In Vitro
Alicia S. Ombredane, Natália Ornelas Martins, Gabriela Mara Vieira de Souza, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1170-1170
Open Access | Times Cited: 1
CYTOTOXIC AND APOPTOTIC EFFECT OF Vernonia amygdalina Delile. FRACTIONS AGAINST Hs578t TRIPLE-NEGATIVE BREAST CANCER CELL LINES
Denny Satria, Poppy Anjelisa Zaitun Hasibuan, Mahatir Muhammad, et al.
Phytomedicine Plus (2024), pp. 100640-100640
Open Access | Times Cited: 1
Multifunctional Cerium oxide-Copper oxide Nanocomposites: One-Pot Engineering Precipitation for Enhanced Antimicrobial, Antioxidant and Anticancer Activities
P.K. Abhilash, P. Jegajeevanram, P. Prabu, et al.
Journal of the Indian Chemical Society (2024), pp. 101525-101525
Closed Access
Targeting Refractory Triple-Negative Breast Cancer with Sacituzumab Govitecan: A New Era in Precision Medicine
Saif Khan, Suresh Babu Jandrajupalli, Nashwa Zaki Ali Bushara, et al.
Cells (2024) Vol. 13, Iss. 24, pp. 2126-2126
Open Access
Page 1

Scroll to top